Trauma Primes Cells

这项申请是我们资助的2000年创伤中心申请的延伸，也是我们竞争性续期的重新提交，该续期获得了2004-2005年的桥梁资金。我们的总体假设是，人类核心（容纳临床数据库和患者样本）与炎症信号传导机制研究之间的双向交流将有助于我们设计创伤原代细胞的治疗方法。自1993年首次资助以来，我们的MOF数据库已大幅增长，对出血性休克（I）、输血（II）、组织损伤（IV）和心肺复苏机制（V）固有的基本问题产生了新的见解。这些项目仍然高度依赖彼此，并邀请人类核心进一步测试假设。Silliman的项目对淋巴和储存血液中积累的类似脂质代谢物进行了详细分析，重点是肺内皮。Abraham的项目专注于另一种普遍存在的细胞内蛋白HMGBP，它可能是由细胞因子或LPS引起的炎症的倒数第二个效应物。奇怪的是，它的信号传导机制可能导致相同的LPS受体途径。Banerjee的项目挑战了其他项目， 由炎症介质依赖于大的信号复合物，形成激活受体被内化。因此，通过破坏内体支架信号模块的组装，可以避免炎症表现。为了验证这些想法，Human Core负责提供样本，收集数据，并重新注释数据库，同时保持严格的法规遵从性。随着年轻的临床医生和生物统计学家返回查询这个强大的数据库，我们重新评估改变治疗的影响，并为未来周期的实验室测试开发新的假设。一个充满活力的细胞和成像核心将为每个项目提供常用的人类细胞，设备和专业知识，以使用抗体进行先进的分子共定位和细胞计数。这些努力得到了一个经验丰富的行政核心的支持，该核心寻求进一步加强我们三个机构的实力， 公布创伤研究

This application is an extension of our funded 2000 Trauma Center application and a resubmission of our competing renewal that was awarded bridge funding for 2004-2005. Our global hypothesis is that two-way exchanges between Human Core (housing clinical databases and patient samples) with mechanistic studies of inflammatory signaling will help us devise THERAPY FOR TRAUMA PRIMES CELLS. Since initial funding in 1993, our MOF databases have grown substantially to yield novel insights into fundamental problems inherent to hemorrhagic shock (I), transfusion (II), tissue injury (IV) and mechanisms of antiinflammatory resuscitation (V). The projects remain highly dependent on each other, and invite the Human Core to further test hypotheses. Project by Silliman undertakes a detailed analysis of analogous lipid metabolites accruing in lymph and stored blood, focusing on lung endothelium. Project by Abraham focuses on another type of ubiquitous intracellular protein HMGBP that may be the penultimate effector of inflammation, caused by either cytokines or LPS. Curiously, its signaling mechanism could lead to the same LPS receptor pathway. Project by Banerjee challenges other projects that signaling by inflammatory agents depends on large signaling complexes that form as activated receptors are internalized. Therefore, by disrupting assembly of the endosome-scaffolded signaling modules, inflammatory manifestations might be avoided. To validate these ideas, the Human Core is charged with supplying specimens, gather data, and re-annotate the database while remaining in strict regulatory compliance. With young clinicians and bio-statisticians returning to query this powerful database, we reassess the impact of changing therapy and develop new hypotheses for bench-testing in future cycles. A vigorous Cell & Imaging Core will provide each project with commonly used human cells, and equipment and expertise to perform advanced molecular colocalization and cytometry using antibodies. These efforts are supported by a seasoned Administrative Core that seeks to further the prowess of our three institutions to promulgate Trauma Research.